Clinical trial
Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
NCT00000392 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
- Lead sponsor
- National Institute of Mental Health (NIMH)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 1990
- Completion date
- August 31, 1996
- Enrollment
- 215 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.